Oncogenic senescence: a multi-functional perspective

Darren J. Baker; Fatouma Alimirah; Jan M. van Deursen; Judith Campisi; Jeffrey Hildesheim

doi:10.18632/oncotarget.15742

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meeting Reports:

Oncogenic senescence: a multi-functional perspective

Darren J. Baker _, Fatouma Alimirah, Jan M. van Deursen, Judith Campisi and Jeffrey Hildesheim

PDF | HTML | How to cite

Oncotarget. 2017; 8:27661-27672. https://doi.org/10.18632/oncotarget.15742

Metrics: PDF 2594 views | HTML 3802 views | ?

Abstract

Darren J. Baker1,2,*, Fatouma Alimirah3,*, Jan M. van Deursen1,2, Judith Campisi3 and Jeffrey Hildesheim4

1 Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA

2 Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA

3 Buck Institute for Research on Aging, Novato, California, USA

4 Division of Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

* These authors have contributed equally to this work

Correspondence to:

Darren J. Baker, email:

Fatouma Alimirah, email:

Keywords: cellular senescence, tumorigenesis, microenvironment

Received: November 11, 2016 Accepted: November 14, 2016 Published: February 25, 2017

Abstract

Cellular senescence is defined as an irreversible growth arrest with the acquisition of a distinctive secretome. The growth arrest is a potent anticancer mechanism whereas the secretome facilitates wound healing, tissue repair, and development. The senescence response has also become increasingly recognized as an important contributor to aging and age-related diseases, including cancer. Although oncogenic mutations are capable of inducing a beneficial senescence response that prevents the growth of premalignant cells and promotes cancer immune-surveillance, the secretome of senescent cells also includes factors with pro-tumorigenic properties. On June 23rd and 24th, 2016, the Division of Cancer Biology of the National Cancer Institute sponsored a workshop to discuss the complex role of cellular senescence in tumorigenesis with the goal to define the major challenges and opportunities within this important field of cancer research. Additionally, it was noted how the development of novel tools and technologies are required to accelerate research into a mechanistic understanding of senescent cells in carcinogenesis in order to overcome the current limitations in this exciting, yet ill-defined area.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15742

Publication Alerts

Meeting Reports:

Oncogenic senescence: a multi-functional perspective

Abstract